These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6188731)

  • 1. The definition of an MB related specificity by a monoclonal antibody.
    Thompson CH; Vaughan HA; McKenzie IF
    Hum Immunol; 1983 Mar; 6(3):133-50. PubMed ID: 6188731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for polymorphism of MB3 antigens among three HLA-D clusters associated with HLA-DR4.
    Ikeda H; Kasahara M; Ogasawara K; Takenouchi T; Okuyama T; Ishikawa N; Wakisaka A; Kikuchi Y; Aizawa M
    Immunogenetics; 1984; 19(5):381-90. PubMed ID: 6202628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
    Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
    J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DS molecules and their relation to supertypic specificities.
    Goyert SM; Moriuchi J; Winchester R; Silver J
    Hum Immunol; 1983 Sep; 8(1):53-63. PubMed ID: 6195135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
    Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
    Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human 'Ia' antigen populations defined by monoclonal antibodies.
    Sparrow RL; McKenzie IF
    J Immunogenet; 1983 Jun; 10(3):179-89. PubMed ID: 6192177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody that detects a polymorphic determinant common to HLA-DR1 and 2.
    Kasahara M; Ogasawara K; Ikeda H; Okuyama T; Ishikawa N; Takenouchi T; Wakisaka A; Kikuchi Y; Aizawa M
    Tissue Antigens; 1983 Feb; 21(2):105-13. PubMed ID: 6189259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules.
    Crepaldi T; Richiardi P; Malavasi F; Carbonara AO; Igarashi M; Ferrone S
    Tissue Antigens; 1985 Jul; 26(1):25-34. PubMed ID: 2412306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants.
    Zeevi A; Scheffel C; Annen K; Bass G; Marrari M; Duquesnoy RJ
    Immunogenetics; 1982; 16(3):209-18. PubMed ID: 6183198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity.
    Giles RC; Nunez G; Hurley CK; Nunez-Roldan A; Winchester R; Stastny P; Capra JD
    J Exp Med; 1983 May; 157(5):1461-70. PubMed ID: 6189938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia. Recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR series.
    Nunez-Roldan A; Szer I; Toguchi T; Cuttner J; Winchester R
    J Exp Med; 1982 Dec; 156(6):1872-7. PubMed ID: 6184437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse monoclonal antibody detects a new polymorphic Ia determinant other than HLA-DR antigen: a possible allele of DC-1.
    Maeda H
    Tissue Antigens; 1984 Mar; 23(3):163-70. PubMed ID: 6427972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interdependent membrane mobility of human MHC coded antigens detected by monoclonal antibodies to various epitopes on class I and II molecules.
    Neppert J; Mueller-Eckhardt C
    Tissue Antigens; 1985 Jul; 26(1):51-9. PubMed ID: 2412307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products.
    Puri NK; de Kretser T; Brandon MR
    Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent expression of HLA-DC/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodies.
    Müller C; Ziegler A; Muller C; Hadam M; Waller HD; Wernet P; Müller G
    Immunobiology; 1985 Apr; 169(3):228-49. PubMed ID: 3873401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
    Yabe T; Suzuki M; Satake M; Juji T; Hamaguchi H
    Immunogenetics; 1984; 20(2):155-67. PubMed ID: 6205988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines.
    Shaw S; Ziegler A; DeMars R
    Hum Immunol; 1985 Apr; 12(4):191-211. PubMed ID: 3921497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.